bpc 157 nervous system Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review Pentadecapeptide BPC 157 and the
Description
Research for new, safer and more effective cyanide antidotes continues (Class IV)

References Liu M, Xue J, Cao Y et al (2024) The effects of nardosinone on levodopa intervention in the treatment of parkinsons disease

Immunol Rev 206:149159

BPC-157 is not approved by Health Canada or the FDA for human use
